Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1166 (LINC01166) is a long non-coding RNA gene, meaning it transcribes an RNA molecule that does not code for a protein. Its specific molecular function, biological role, clinical relevance, or therapeutic potential has not been elucidated in current published sources. Unlike functionally characterized lncRNAs such as LINC01116 or LINC00511, LINC01166 appears in gene listings as an annotated genomic locus with unknown function. There is no evidence supporting its relevance as a therapeutic target, biomarker, or disease-associated gene at this time. LINC01166 is distinct from LINC01116, which is a well-studied oncogenic lncRNA with functions in cancer; the two should not be confused.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1166 (LINC01166).